Seqirus Holdings UK Limited, headquartered in Great Britain, is a prominent player in the global biopharmaceutical industry, specialising in the development and distribution of innovative vaccines. Founded in 2015, Seqirus has quickly established itself as a leader in the field, particularly in the areas of influenza and pandemic preparedness. With a strong operational presence across Europe, North America, and Asia-Pacific, the company is dedicated to enhancing public health through its unique portfolio of products, including seasonal flu vaccines and adjuvanted formulations. Seqirus is recognised for its commitment to research and development, which has led to significant advancements in vaccine technology. As a subsidiary of CSL Limited, Seqirus holds a notable market position, contributing to the global fight against infectious diseases and achieving key milestones in vaccine accessibility and efficacy.
We don't have data for Seqirus Holdings Uk Limited, but we can show you information about their parent organization instead.
View parent company